Immunogenicity of BNT162b2 vaccine booster against SARS-CoV-2 Delta and Omicron variants in nursing home residents: A prospective observational study in older adults aged from 68 to 98 years - The Lancet Regional
Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant - ScienceDirect
Immune imprinting and SARS-CoV-2 vaccine design: Trends in Immunology
COVID vaccine booster increases antibody responses, is protective in rhesus macaques | National Institutes of Health (NIH)
JCI - Durability of immune responses to mRNA booster vaccination against COVID-19
Interval between prior SARS-CoV-2 infection and booster vaccination impacts magnitude and quality of antibody and B cell responses - ScienceDirect
SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination | NEJM
Durability of Booster mRNA Vaccine against SARS-CoV-2 BA.2.12.1, BA.4, and BA.5 Subvariants | NEJM
Moderna 2-strain booster shows strong subvariant antibody response | CIDRAP
COVID antibodies appear to wane rapidly, so prepare for booster shots, study suggests – The Vacaville Reporter
Antibody response after a booster dose of SARS-CoV-2 vaccine in liver transplant recipients and those with chronic liver diseases | Annals of Hepatology
Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort study - eClinicalMedicine
Initial SARS-CoV-2 vaccination response can predict booster response for BNT162b2 but not for AZD1222 - ScienceDirect
Spike-antibody waning after second dose of BNT162b2 or ChAdOx1 - The Lancet
Boosting immunity to Omicron | Nature Medicine
JKMS :: Journal of Korean Medical Science
Vaccines | Free Full-Text | The Four Ws of the Fourth Dose COVID-19 Vaccines: Why, Who, When and What
Prof. Akiko Iwasaki on X: "Why do we need a booster shots? This is because B cell responses induced by first dose only generates lower levels, lower affinity and short lived antibody
Epitope masking may limit antibody boosting to malaria vaccines - Kurtovic - 2021 - Immunology & Cell Biology - Wiley Online Library
Antibody Response to the BA.5 Bivalent Vaccine Shot: a Two-Year Follow-Up Study following Initial COVID-19 mRNA Vaccination | Microbiology Spectrum
Antibody titers in turkeys increase after multiple booster vaccinations with an attenuated Salmonella live vaccine | BMC Research Notes | Full Text
Antibody Response to Omicron BA.4–BA.5 Bivalent Booster | NEJM
Vaccines | Free Full-Text | Heterologous Booster Dose with CORBEVAX following Primary Vaccination with COVISHIELD Enhances Protection against SARS-CoV-2
Moderna's Omicron Booster Increases Antibody Levels | Time
